Scientists Breakthrough in Key Technology for 3D - Printed Organs: Rapid Generation of Vascular Networks
Release time:
2025-06-27
Recently, the team led by Alison Marsden from Stanford University in the United States published a significant breakthrough in the journal Science. They successfully developed a computational model that can rapidly design the vascular network for 3D - printed organs. This technology is expected to greatly reduce the manufacturing time of artificial organs and offer new solutions to the problem of organ transplantation shortage.
Breakthrough Technology: Minute - Level Vascular Network Design
Currently, one of the biggest challenges in 3D - printing organs is constructing a fully functional vascular network. Traditional methods take days or even weeks to design the blood vessels. However, the computational model developed by the Marsden team, based on the mathematical laws of blood vessel branching, can generate an optimized vascular network for any organ within minutes.
The researchers used a 1 - centimeter - wide ring structure 3D - printed with kidney cells as the experimental object. They designed a network consisting of 25 blood vessels in just a few minutes. Then, they used the cold gelatin particle printing technology. By melting the gelatin at 37°C, they created 1 - millimeter - wide hollow blood vessel channels. The experiment showed that this vascular network can significantly improve cell survival rates. After one week, the number of viable cells in the kidney cell ring with the implanted blood vessels increased by about 400 times, while the cell survival rate in the control group without blood vessel implantation was extremely low.
Clinical Prospects: Animal Experiments May Be Conducted within 5 Years
Although this technology is still in its early stage, the research team is full of confidence in its future applications. Marsden said, "We can keep the cells close to the blood vessels alive, but the cells at a greater distance will still die due to lack of nutrients. Next, we will optimize the printing technology for finer and more branched blood vessels."
Hugues Talbot from the University of Paris - Saclay commented, "This method may enable scientists to complete the vascular network design for full - sized organs within hours instead of days or weeks." The research team plans to develop a blood vessel printing method suitable for large organs in the future and hopes to conduct transplantation experiments on large animals such as pigs within 5 years.
Great Significance: Promoting the Commercialization of Artificial Organs
Globally, a large number of patients wait for organ transplants due to organ failure every year, but the supply of donors is severely insufficient. If 3D - printed organs can achieve the rapid construction of vascular networks, it will greatly accelerate the research and development process of artificial organs and is expected to relieve the problem of organ shortage in the future.
This breakthrough marks a crucial step for 3D bioprinting technology towards clinical application. The research team said that their long - term goal is to establish a standardized production process for artificial organs and ultimately achieve a more efficient organ replacement solution. With the continuous progress of stem cell technology and bioprinting technology, personalized customized organs may become a reality in the future, completely changing the medical model of human organ transplantation.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
